恶性黑色素瘤MYBL2/CDCA8信号通路之间的相关性
Chen Wu1, Jiahui Jiang1, Chao Ci1
1Department of Dermatology, The First Affiliated Hospital of Wannan Medical College, No. 2 Zheshan West Road, Wuhu, Anhui, 241001, China.
Heliyon
|July 4, 2024
概括
类似于2的MYB原型瘤基因 (MYBL2) 通过调节与细胞分裂周期相关的8 (CDCA8) 表达,促进恶性黑色素瘤细胞迁移和入侵. 这项研究揭示了MYBL2作为黑色素瘤的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 皮肤恶性黑色素瘤是一种具有显著死亡率的侵袭性皮肤癌.
- 了解驱动黑色素瘤进展的分子机制对于开发有效的治疗方法至关重要.
研究的目的:
- 研究MYB原瘤基因2 (MYBL2) 在调节细胞分裂周期关联8 (CDCA8) 表达中的作用.
- 确定MYBL2介导的CDCA8调节对皮肤恶性黑色素瘤细胞的生物活性的影响.
主要方法:
- 使用了A375黑色素瘤细胞与MYBL2和CDCA8过度表达和淘汰.
- 评估细胞迁移,入侵和增殖,使用体外测试.
- 通过流细胞计量量化亡,并在裸体小鼠体内评估瘤发生潜力.
主要成果:
- 与正常细胞相比,黑色素瘤细胞中MYBL2和CDCA8的表达升高.
- 降低MYBL2的调控减少了黑色素瘤细胞的迁移和入侵,而过度表达则增强了这些过程.
- 在MYBL2和CDCA8表达之间观察到正相关性.
- 在体内研究表明,MYBL2的淘汰显著降低了瘤体积和CDCA8的表达.
结论:
- MYBL2促进皮肤恶性黑色素瘤细胞的迁移,入侵和增殖.
- 通过有针对性的调节CDCA8表达来实现这种促进.
- MYBL2代表了黑色素瘤治疗的潜在治疗点.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
MAPK Signaling Cascades
5.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K


